Regulator warns on congential heart defects with SSRI

The UK medicines regulator has warned of a ‘possible small risk’ of congenital heart defects when prescribing the selective-serotonin reuptake inhibitor fluoxetine.

Other News
School split sparks jobs hope
BMA daily feed
Historic conjoined twins surgery set for today
Regional news
Data Illustrate Geographic Dispersal of Family Physicians, Other Primary Care Professionals
AAFP News Now
AAFP Task Force Releases New Draft of Proposed Bylaws
AAFP News Now
Profile of specialist route raised
BMA daily feed
PM reveals new manifesto promises
Regional news
AAFP, Other Physician Groups Deliver Unified SGR Message to Capitol Hill
AAFP News Now
more